Article Text

Download PDFPDF

Research Letter
Emerging impact of the COVID-19 outbreak on sexual health in Lebanon
Free
  1. Ismael Maatouk1,2,
  2. Moubadda Assi3,
  3. Rusi Jaspal4
  1. 1Dermatology, Clemenceau Medical Center, Beirut, Lebanon
  2. 2Faculty of Health and Life Sciences, De Montfort University, Leicester, UK
  3. 3National AIDS Program, Beirut, Lebanon
  4. 4School of Social Sciences, Nottingham Trent University, Nottingham, Nottinghamshire, UK
  1. Correspondence to Dr Ismael Maatouk, Dermatology, Clemenceau Medical Center, Beirut, Lebanon; ismael.maatouk{at}cmc.com.lb

Statistics from Altmetric.com

Dear Editor,

Lebanon registered its first COVID-19 case on 21 February 2020, which was followed by a nationwide lockdown (15 March–8 June), resulting in strict curfews, the prohibition of public gatherings and the closure of the international airport in Beirut.1 The pandemic has had compounding effects on the political and economic crisis with severe economic and health consequences.2

Throughout the lockdown, one of the largest sexually transmitted infections (STIs) and HIV clinics in Beirut with linkages to major civil organisations in direct contact with sexual health beneficiaries has remained open for emergencies such as postexposure prophylaxis (PEP) for HIV and STI testing in people exposed to risk. Access to remote consultations has also been available. The clinic has noted a major reduction in STI testing rates. Only 26 screenings were recorded in the lockdown period, which contrasts with the 97 screenings conducted during the same period of 2019 (73% drop in 2020). All the screenings were among men who have sex with men (MSM). There were four diagnoses of STIs (one of urethral Neisseria gonorrhoea and three of urethral Chlamydia trachomatis, and no cases of syphilis or HIV), which significantly contrasts with the previous numbers of STIs (44 in 2018 and 53 in 2019) in the same time frame among MSM.3

On the other hand, PEP was prescribed 36 times in the period January–June 2020 compared with 27 times during the same period of time in 2019 (34% increase). All cases of PEP prescriptions were for MSM. A range of risky behaviours and a 12% prevalence of HIV have been documented in MSM in Lebanon.3

The lockdown measures and fear of infection with COVID-19 may have directly affected the willingness of patients to access screening services. However, the increase in PEP prescription for MSM indicates that sexual risk-taking has persisted despite potential fear of contracting COVID-19. Our results contrast with findings from Australia and Rome, where COVID-19 restrictions have resulted in effective social distancing and consequently a reduction of casual sexual encounters in MSM.4 5 Three factors could explain the difference between Lebanon and these countries. First, the already existent political and economic instability, along with the new pandemic, may act as psychological stressors, which in turn may lead to self-medicating behaviours, including sexual risk-taking, in the general population. In MSM, in particular, it has been shown that social psychological stressors may threaten identity and well-being, leading individuals to resort to sexual risk behaviours when decreased social support is available.2 Second, while there was a reduction in sexual encounters in MSM in Italy and Australia, sexual risk-taking continued in Lebanese MSM, although individuals may have prioritised HIV prevention over other STIs during the lockdown. Third, data on epidemiology of STIs in COVID-19 time are inconsistent due to the lack of stratification by incubation period, acute versus chronic type, duration of symptoms and sexual orientation. Future studies should ascertain the impact of COVID-19 on both mental and sexual health especially in stigmatised communities such as MSM.

References

View Abstract

Footnotes

  • Handling editor Anna Maria Geretti

  • Twitter @ismaelmaatouk, @boudyassi, @ProfRJaspal

  • Contributors IM drafted the paper; MA reviewed data and RJ reviewed the overall paper. The three authors approved this final version.

  • Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

  • Competing interests None declared.

  • Patient consent for publication Not required.

  • Provenance and peer review Not commissioned; externally peer reviewed.

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.